Posts by rw-admin
Medtronic Partnership Reveals New Details About Surgical Robotics Project
Medtronic won’t unveil its new robot-assisted surgery platform until the fall, but a recent announcement from the company offered a sneak peek at what’s coming. The medical device giant yesterday disclosed a partnership with Karl Storz SE & Co. (Tuttlingen, Germany) to use Karl Storz’s three-dimensional vision systems and visualization components into Medtronic’s upcoming robot-assisted surgical…
Read MoreZoll Buys AED Developer Cardiac Science
Cardiac Science Corporation, a leading provider of automated external defibrillators (AEDs), related services and accessories, today announced it has entered into a definitive agreement to be acquired by ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions. CSC is a portfolio company of Aurora Resurgence, a Los Angeles-based…
Read MoreNexus Ultrasonic Surgical Platform from Misonix FDA Cleared
Misonix, Inc., a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, today announced that it received 510(k) clearance by the U.S. Food and Drug Administration (FDA) for Nexus, its revolutionary ultrasonic surgical platform. Misonix will commence the commercialization of the Nexus platform in the United States in July. Nexus is a…
Read MoreMedivis Wins FDA Clearance for Breakthrough Augmented Reality Surgical System
Medivis announced today that its groundbreaking augmented reality (AR) technology platform for surgical applications, SurgicalAR, has received 510(k) clearance for clinical use in the operating room by the U.S. Food and Drug Administration. The New York City based medical technology company will commence the immediate commercialization of the platform in the United States. The enterprise SurgicalAR platform integrates the…
Read MoreClearFlow Announces Positive Trial Results for PleuraFlow Thoracic Evacuation Device
ClearFlow, Inc., a medical device company based in Anaheim, California, has announced that positive clinical trial results of its PleuraFlow® device were presented at the American Association for Thoracic Surgery (AATS) 99th Annual meeting on May 4 in Toronto, Canada. This new data stems from a trial evaluating the use of ClearFlow’s PleuraFlow® Active Clearance…
Read MoreMedtronic to acquire Titan Spine
Medtronic said last week that it agreed to acquire Titan Spine for an undisclosed amount. Mequon, Wis.-based Titan Spine makes a line of titanium interbody fusion devices featuring a surfacing technology it developed to encourage the ingrowth of bone into the implants. The acquisition is slated to close during Medtronic’s fiscal first quarter ending July 26,…
Read MoreFirst Medical Device Treatment for Childhood ADHD Cleared by FDA
NeuroSigma won de novo clearance from the FDA last week to put the first medical device for treating attention-deficit hyperactivity disorder on the U.S. market. Los Angeles-based NeuroSigma makes the Monarch eTNS system, which is designed to deliver mild electrical signals through a forehead patch to stimulate branches of the trigeminal nerve during sleep. The device won CE Mark approval…
Read MoreExactech Announces First Successful Surgeries Using InterSep Bone Void Filler
Exactech, a developer and producer of bone and joint restoration products for extremities, hip, and knee, announced today the successful first surgery using its new InterSepTM calcium sulfate bone void filler. One of the newest additions to Exactech’s infection-related solutions, InterSep is a 100% synthetic calcium sulfate bone void filler that is engineered to fully resorb and…
Read MoreElucent Medical Wins FDA Clearance for New Breast Surgery Navigation System
Elucent Medical, a company dedicated to developing better pathways for breast cancer care, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the clinical use of the company’s EnVisio™ Surgical Navigation System. Placed at the time of the breast biopsy, Elucent Medical’s permanently implantable wireless SmartClip™ Soft Tissue Marker…
Read MoreFirst-Ever Clinical Trial Initiated for Neural Interface that Turns Thoughts into Speech
Synchron, Inc. today announced the initiation of the first clinical trial for the Stentrode™, a minimally-invasive neural interface technology being investigated for restoration of communication in people with severe paralysis. The trial will evaluate the safety of Thought-to-Text™ technology in patients, by assessing the Stentrode implant in combination with BrainOS™ software. The Stentrode is designed to record brain activity…
Read More